New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells

Bone

Volumn 45, Issue 1, 2009, Pages 27-41

  Lavery, Karen ^a   Hawley, Sara ^a   Swain, Pamela ^a   Rooney, Robert ^b   Falb, Dean ^a   Alaoui Ismaili, Moulay Hicham ^a  

^a Stryker Orthopaedics   (United States)

^b Genome Explorations Inc   (United States)

Author keywords

BMP 7 (OP 1); Bone morphogenetic protein; Gene expression; Mesenchymal stem cell; Osteoblast

Indexed keywords

ADAMTS9 PROTEIN; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 2; CHITINASE 3 LIKE 1 PROTEIN; DIO2 PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GROWTH DIFFERENTIATION FACTOR 5; HEY1 PROTEIN; HYALURONAN SYNTHASE 3; MFI2 PROTEIN; OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN GENOME; MESENCHYMAL STEM CELL; OSTEOBLAST; UPREGULATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 7; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; CLUSTER ANALYSIS; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION PROFILING; GLYCOPROTEINS; GROWTH DIFFERENTIATION FACTOR 5; HUMANS; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOBLASTS; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 67349155526     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.03.656     Document Type: Article

References (56)

1. Ducy P., Schinke T., and Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 289 (2000) 1501-1504
2. Gautschi O.P., Frey S.P., and Zellweger R. Bone morphogenetic proteins in clinical applications. ANZ J. Surg. 77 (2007) 626-631
3. Sebald W., Nickel J., Zhang J.L., and Mueller T.D. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol. Chem. 385 (2004) 697-710
4. Zhao M., Zhao Z., Koh J.T., Jin T., and Franceschi R.T. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J. Cell. Biochem. 95 (2005) 1-16
5. Tsiridis E., Bhallaa A., Alia Z., Gurava N., Heliotisa M., Deba S., et al. Enhancing the osteoinductive properties of hydroxyapatite by the addition of human mesenchymal stem cells, and recombinant human osteogenic protein-1 (BMP-7) in vitro. Injury 37 (2006) S25-S32
6. Kirker-Head C., Karageorgiou V., Hofmann S., Fajardo R., Betz O., Merkle H.P., et al. BMP-silk composite matrices heal critically sized femoral defects. Bone (2007)
7. Tai K., Pelled G., Sheyn D., Bershteyn A., Han L., Kallai I., et al. Nanobiomechanics of repair bone regenerated by genetically modified mesenchymal stem cells. Tissue Eng. Part A (2008)
8. Uchida M., Agata H., Sagara H., Shinohara Y., Kagami H., and Asahina I. Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2. J. Biomed. Mater. Res. A. (2008)
9. Lavery K., Swain P., Falb D., and Alaoui-Ismaili M.H. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J. Biol. Chem. 283 (2008) 20948-20958
10. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267 (1992) 20352-20362
11. Lockhart D.J., Dong H., Byrne M.C., Follettie M.T., Gallo M.V., Chee M.S., et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14 (1996) 1675-1680
12. Liu W.M., Mei R., Di X., Ryder T.B., Hubbell E., Dee S., et al. Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics 18 (2002) 1593-1599
13. Hubbell E., Liu W.M., and Mei R. Robust estimators for expression analysis. Bioinformatics 18 (2002) 1585-1592
14. Irizarry R.A., Wu Z., and Jaffee H.A. Comparison of Affymetrix GeneChip expression measures. Bioinformatics 22 (2006) 789-794
15. Zhang B., Kirov S., and Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33 (2005) W741-W748
16. Marrony S., Bassilana F., Seuwen K., and Keller H. Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone 33 (2003) 426-433
17. Ryoo H.M., Lee M.H., and Kim Y.J. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 366 (2006) 51-57
18. Kim Y.J., Kim H.N., Park E.K., Lee B.H., Ryoo H.M., Kim S.Y., et al. The bone-related Zn finger transcription factor osterix promotes proliferation of mesenchymal cells. Gene 366 (2006) 145-151
19. Gazzerro E., Gangji V., and Canalis E. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J. Clin. Invest. 102 (1998) 2106-2114
20. Diefenderfer D.L., Osyczka A.M., Garino J.P., and Leboy P.S. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J. Bone Joint Surg., Am. 85-A Suppl 3 (2003) 19-28
21. Pereira R.C., Economides A.N., and Canalis E. Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts. Endocrinology 141 (2000) 4558-4563
22. Grotewold L., Plum M., Dildrop R., Peters T., and Ruther U. Bambi is coexpressed with Bmp-4 during mouse embryogenesis. Mech. Dev. 100 (2001) 327-330
23. Spanner M., Weber K., Lanske B., Ihbe A., Siggelkow H., Schutze H., et al. The iron-binding protein ferritin is expressed in cells of the osteoblastic lineage in vitro and in vivo. Bone 17 (1995) 161-165
24. Cornish J., Callon K.E., Naot D., Palmano K.P., Banovic T., Bava U., et al. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145 (2004) 4366-4374
25. Cornish J., Palmano K., Callon K.E., Watson M., Lin J.M., Valenti P., et al. Lactoferrin and bone; structure-activity relationships. Biochem. Cell. Biol. 84 (2006) 297-302
26. Sharff K.A., Song W.X., Luo X., Tang N., Luo J., Chen J., et al. Hey1 basic helix-loop-helix (bHLH) protein plays an important role in mediating BMP9 induced osteogenic differentiation of mesenchymal progenitor cells. J. Biol. Chem. (2008)
27. de Jong D.S., Vaes B.L., Dechering K.J., Feijen A., Hendriks J.M., Wehrens R., et al. Identification of novel regulators associated with early-phase osteoblast differentiation. J. Bone Miner. Res. 19 (2004) 947-958
28. Hilton M.J., Tu X., Wu X., Bai S., Zhao H., Kobayashi T., et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med. 14 (2008) 306-314
29. Bianco A.C., Salvatore D., Gereben B., Berry M.J., and Larsen P.R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23 (2002) 38-89
30. Williams A.J., Robson H., Kester M.H., van Leeuwen J.P., Shalet S.M., Visser T.J., et al. Iodothyronine deiodinase enzyme activities in bone. Bone 43 (2008) 126-134
31. Gouveia C.H., Christoffolete M.A., Zaitune C.R., Dora J.M., Harney J.W., Maia A.L., et al. Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. Endocrinology 146 (2005) 195-200
32. Varga F., Rumpler M., Luegmayr E., Fratzl-Zelman N., Glantschnig H., and Klaushofer K. Triiodothyronine, a regulator of osteoblastic differentiation: depression of histone H4, attenuation of c-fos/c-jun, and induction of osteocalcin expression. Calcif. Tissue Int. 61 (1997) 404-411
33. Kassem M., Mosekilde L., and Eriksen E.F. Effects of triiodothyronine on DNA synthesis and differentiation markers of normal human osteoblast-like cells in vitro. Biochem. Mol. Biol. Int. 30 (1993) 779-788
34. Galindo M., Pratap J., Young D.W., Hovhannisyan H., Im H.J., Choi J.Y., et al. The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J. Biol. Chem. 280 (2005) 20274-20285
35. Thomas D.M., Carty S.A., Piscopo D.M., Lee J.S., Wang W.F., Forrester W.C., et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell. 8 (2001) 303-316
36. Mogi M., and Togari A. Activation of caspases is required for osteoblastic differentiation. J. Biol. Chem. 278 (2003) 47477-47482
37. Ishimi Y., Miyaura C., Jin C.H., Akatsu T., Abe E., Nakamura Y., et al. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 145 (1990) 3297-3303
38. Sato T., Hakeda Y., Yamaguchi Y., Mano H., Tezuka K., Matsumoto K., et al. Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/PA6). J. Cell. Physiol. 164 (1995) 197-204
39. Grano M., Galimi F., Zambonin G., Colucci S., Cottone E., Zallone A.Z., et al. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 7644-7648
40. Li X., Qin L., Bergenstock M., Bevelock L.M., Novack D.V., and Partridge N.C. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J. Biol. Chem. 282 (2007) 33098-33106
41. Grassi F., Cristino S., Toneguzzi S., Piacentini A., Facchini A., and Lisignoli G. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J. Cell. Physiol. 199 (2004) 244-251
42. Nakagawa M., Kaneda T., Arakawa T., Morita S., Sato T., Yomada T., et al. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett. 473 (2000) 161-164
43. Horowitz M.C., Xi Y., Wilson K., and Kacena M.A. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev. 12 (2001) 9-18
44. Chubinskaya S., Hurtig M., and Rueger D.C. OP-1/BMP-7 in cartilage repair. Int. Orthop. (2007)
45. Gould S.E., Day M., Jones S.S., and Dorai H. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. 61 (2002) 51-60
46. Maric I., Poljak L., Zoricic S., Bobinac D., Bosukonda D., Sampath K.T., et al. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J. Cell. Physiol. 196 (2003) 258-264
47. Hruska K.A., Guo G., Wozniak M., Martin D., Miller S., Liapis H., et al. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am. J. Physiol., Renal. Physiol. 279 (2000) F130-F143
48. Mountziaris P.M., and Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng. Part B Rev. 14 (2008) 179-186
49. White A.P., Vaccaro A.R., Hall J.A., Whang P.G., Friel B.C., and McKee M.D. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int. Orthop. (2007)
50. Connor J.R., Dodds R.A., Emery J.G., Kirkpatrick R.B., Rosenberg M., and Gowen M. Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization. Osteoarthr. Cartil. 8 (2000) 87-95
51. Johansen J.S., Stoltenberg M., Hansen M., Florescu A., Horslev-Petersen K., Lorenzen I., et al. Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatol. (Oxf.) 38 (1999) 618-626
52. Trudel G., Recklies A., and Laneuville O. Increased expression of chitinase 3-like protein 1 secondary to joint immobility. Clin. Orthop. Relat. Res. 456 (2007) 92-97
53. Jacques C., Recklies A.D., Levy A., and Berenbaum F. HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions. Osteoarthr. Cartil. 15 (2007) 138-146
54. De Ceuninck F., Gaufillier S., Bonnaud A., Sabatini M., Lesur C., and Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem. Biophys. Res. Commun. 285 (2001) 926-931
55. Erlacher L., McCartney J., Piek E., ten Dijke P., Yanagishita M., Oppermann H., et al. Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis. J. Bone Miner. Res. 13 (1998) 383-392
56. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 38 (2006) 1424-1429